Stem cell therapies continue to advance. The holy grail, however, is to be able to regenerate failing organs and tissues. Tobias Deuse, MD, and his research group believe they now know why some transplanted cells are rejected. He believes the solution is to engineer stem cells lacking any immune features.
Source: The Conversation, August 19, 2019. Link.
INSIGHTS: Animal health pros following stem cell use and development will find Deuse’s article informative and promising.